04.21.25 -- Bringing Your mRNA-Based Drug From Pre-Clinical To Commercial

Discover high-quality consumables and analysis kits that are designed to enhance the accuracy and efficiency of nucleic acid analysis from genomic DNA and RNA analysis to quality control of NGS.

20L Flexsafe bags are the most appropriate format and a cGMP manufacturing process using WFI-quality water ensure the highest level of quality for a product.

Meet your mRNA product's specific needs with assay packages that provide the product and process knowledge needed to develop a quality target product profile and identify critical quality attributes.

Watch to explore how you can speed up your mRNA-based drug projects, reduce risks, and shorten time to market with comprehensive and seamless processes from pre-clinical development to commercialization.

Discover how revolutionary and environmentally sustainable nanoparticle technologies coupled with innovative formulation approaches can address drug solubility issues and add value for patients.

By combining disruptive technology platforms with unparalleled genomic medicine development expertise, we're positioned to accelerate the development of LNP formulations and drug products.

Meet our ÄKTA oligosynt oligonucleotide synthesizer – a small system with a big impact up to 12 mmol.

Discover how our advanced capabilities in Hopkinton, MA, are overcoming the challenges of large-scale RNA therapeutic manufacturing, enabling the efficient production of complex srRNA and mRNA therapies.

Rare Disease clinical studies demand a specialized full-service CRO with expertise in enrollment, site selection, and global regulatory knowledge, including access to patient registries for accelerated recruitment.

Discover cutting-edge equipment featuring high-pressure dosing technology that enables the efficient production of LNPs for diverse applications.

Unlock automated, precise biomolecular structure measurements from a single drop. Gain cleaner, faster, more critical insights into your biomolecules with this innovative solution.

Learn more about CustomBiotech's mRNA raw materials pipeline and strict quality criteria that are designed to support the success of our customers’ manufacturing scale-up and regulatory drug approval.

The hfCas12Max nuclease offers superior gene editing with high fidelity, broad PAM recognition, minimal off-target effects, and compatibility across cell types for therapeutic applications.

Battelle’s HIT SCAN platform accelerates gene therapy by using high-throughput methods to design, screen, and optimize polymer nanoparticles (PNPs) for effective, non-viral delivery.